Cargando…
miR-588 is a prognostic marker in gastric cancer
In an effort to identify a novel microRNA (miRNA) as a gastric cancer (GC) treatment target and prognostic biomarker, we surveyed The Cancer Genome Atlas database and found that miR-588 expression is low in GC tissues. This was confirmed by real-time reverse transcription polymerase chain reaction a...
Autores principales: | Chen, Yongyi, Zhang, Jie, Gong, Wangang, Dai, Wumin, Xu, Xiaohong, Xu, Songxiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880400/ https://www.ncbi.nlm.nih.gov/pubmed/33323542 http://dx.doi.org/10.18632/aging.202212 |
Ejemplares similares
-
MiR-596 down regulates SOX4 expression and is a potential novel biomarker for gastric cancer
por: Chen, Yongyi, et al.
Publicado: (2020) -
E2F1/2/4 mRNA is associated with immune infiltration and are potential biomarkers for the prognosis of human gastric carcinoma
por: Chen, Yongyi, et al.
Publicado: (2021) -
Metformin up-regulated miR-107 expression and enhanced the inhibitory effect of miR-107 on gastric cancer growth
por: Chen, Yongyi, et al.
Publicado: (2020) -
Erratum to metformin up-regulated miR-107 expression and enhanced the inhibitory effect of miR-107 on gastric cancer growth
por: Chen, Yongyi, et al.
Publicado: (2020) -
Prognostic Value of Liver Kinase B1 (LKB1) in Gastric Cancer-Associated Tumor Microenvironment Immunity
por: Chen, Yongyi, et al.
Publicado: (2023)